Autologous Adipose-Derived Tissue Matrix Part II: Implantation Biology.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Tissue Engineering

Background:

• Liposuctioned fat contains autologous collagen forming a cross-linked helical matrix (Types II, III, IV).
• This matrix includes viable adipocytes and fibroblasts, suggesting potential for tissue regeneration.

Purpose of the Study:

• To evaluate the biological performance of a processed fat-derived collagen matrix after implantation.
• To compare its efficacy and biocompatibility against a common soft tissue filler, Juvederm.

Main Methods:

• Autologous fat was processed into a connective tissue matrix and cryo-frozen.
• The matrix was implanted in nude mice and followed for one year, with Juvederm as a control.
• Histological analysis was performed at 3, 6, 9, and 12 months.

Main Results:

• No adverse effects or significant bio-reactivity (rating 0) were observed for either the fat matrix or Juvederm.
• The implanted fat-derived collagen matrix showed favorable comparison to Juvederm throughout the study period.
• Histology indicated the implanted matrix was replaced by host-derived new collagen and adipose tissue.

Conclusions:

• Processed and cryo-frozen liposuctioned fat yields a collagen matrix with viable cells for autologous use.
• This biomaterial demonstrates sustained presence for at least one year post-implantation.
• The matrix undergoes gradual remodeling, being replaced by endogenous collagen and fat, indicating successful integration.